Hypertension Trial, Recruiting (NCT07106294)

Hypertension Trial, Recruiting NCT07106294 Sponsor: Heidelberg University Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT07106294 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are pregnant with one baby (not twins or more)
People who are 18 years of age or older
People who are able to understand and agree to take part in the study
People who are able to sign a written consent form
People who are already scheduled for a routine ultrasound scan during the first or second trimester of pregnancy

Who may not be able to join:

People who are unable or unwilling to give consent to participate
People who face a language barrier that prevents them from understanding the study
People whose baby has already been found to have a serious chromosomal, genetic, or structural problem at the time of joining the study
People who have smoked in the two hours before the study measurement is taken
People who have already been diagnosed with preeclampsia (a pregnancy-related condition involving high blood pressure) at the time of joining the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dr. med. Alexandra von Au, University Heidelberg

Phone: +49 6221 56 32080

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07106294

Sponsor: Heidelberg University

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

Trial contact: +49 6221 56 32080

More information: https://clinicaltrials.gov/study/NCT07106294

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are pregnant with one baby (not twins or more)
People who are 18 years of age or older
People who are able to understand and agree to take part in the study
People who are able to sign a written consent form
People who are already scheduled for a routine ultrasound scan during the first or second trimester of pregnancy

Who may not be able to join:

People who are unable or unwilling to give consent to participate
People who face a language barrier that prevents them from understanding the study
People whose baby has already been found to have a serious chromosomal, genetic, or structural problem at the time of joining the study
People who have smoked in the two hours before the study measurement is taken
People who have already been diagnosed with preeclampsia (a pregnancy-related condition involving high blood pressure) at the time of joining the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Heidelberg University

Registry

ClinicalTrials.gov

Start date

21 August 2025

Est. completion

1 July 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Number of patients with Preeclampsia; Risk ratio of the preeclampsia screening

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov